Amgen Makes Second Big Move in China With New R&D Center That Will Tap Into Chinese University
This article was originally published in PharmAsia News
Executive Summary
Amgen is building up its first R&D center in China, following its commercial alliance with Beta Pharma. The center will be located at ShanghaiTech University, the new campus in Shanghai Zhangjiang Hi-tech Park.